Isis Pharma (Nasdaq: ISIS) is largely in overbought territory as the stock's recent run is coming to a halt.Market data ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE